Mediators of Inflammation

Mediators of Inflammation / 2017 / Article

Research Article | Open Access

Volume 2017 |Article ID 5309081 | https://doi.org/10.1155/2017/5309081

Lu Liu, Fei Zhou, Pin Wang, Lixiang Yu, Zhongbing Ma, Yuyang Li, Dezong Gao, Qiang Zhang, Liang Li, Zhigang Yu, "Periductal Mastitis: An Inflammatory Disease Related to Bacterial Infection and Consequent Immune Responses?", Mediators of Inflammation, vol. 2017, Article ID 5309081, 9 pages, 2017. https://doi.org/10.1155/2017/5309081

Periductal Mastitis: An Inflammatory Disease Related to Bacterial Infection and Consequent Immune Responses?

Academic Editor: Yona Keisari
Received26 Aug 2016
Revised20 Nov 2016
Accepted06 Dec 2016
Published15 Jan 2017

Abstract

Periductal mastitis (PDM) is a prolonged inflammatory disease, but the cause of PDM is poorly understood. In the present case control study, 87 PDM and 87 healthy controls were enrolled and the results were evaluated to identify the significant risk factors for PDM. To investigate the roles of bacterial infection and critical cytokines expression, 16S rRNA gene sequencing and bacterial culturing were conducted. We also measured the levels of interferon-γ, interleukin-12A, and interleukin-17A by semiquantitative immunohistochemistry method. In a multivariable logistic regression model, we identified overweight/obesity and late onset of menarche as independent risk factors for PDM. In contrast, age of first birth >27 years had a protective effect. With 16S rRNA gene sequencing, we confirmed bacterial infections were found in all PDM patients, but none of the control patients was positive on the gene expression of 16S rRNA. Our results also demonstrated significant increases of the IFN-γ and IL-12A expression in PDM, but there was no difference in IL-17A expression in these two groups. Taken together, this study suggests that reproductive factors and overweight/obesity are possible predisposing risk factors for PDM. Bacterial infection and the increased expression of some proinflammatory cytokines are associated with the pathogenesis of this disease.

1. Introduction

Periductal mastitis (PDM) is histopathologically defined as a chronic inflammation of the breast, with dilation of the mammary duct, plasma cell infiltration, and abscess formation. A variety of different terms, including mammary ductal ectasia and plasma cell mastitis, have been used for this condition [1, 2]. The use of different terms probably reflects different stages in the disease process. In recent years, the morbidity rate of PDM has risen rapidly [3]. Moreover, in several studies, mammary ductal ectasia has been found to be responsible for 5–25% of all symptomatic breast conditions [4, 5]. The clinical presentations of PDM are not specific and are easily confused with breast carcinoma in imaging manifestations [6, 7].

Thus far, the etiology of PDM is still unknown. Several factors have been associated with an increased risk for this disease, including smoking, obesity, and diabetes mellitus. However, all of these stated risks are identified based on small case series reports and have not been confirmed epidemiologically [8, 9]. Although PDM is generally seen in those who smoke heavily [9], some other studies also suggest inconsistent findings with this conclusion [10]. In addition, although obesity is considered as a significant risk factor for PDM [11], this conclusion is also just based on case reports, lacking epidemiological evidence. Literature also indicates conflicting information on whether age at first birth, parity, and duration of breastfeeding are potential risk factors for PDM [4, 12]. Moreover, while some studies claim that ethnicity is associated with PDM [13], these studies were limited to a few of geographical areas and races since all data are concluded from small scale studies. Furthermore, as we have known now, the data on the predisposing factors for PDM in Chinese patients is very rare too.

Etiologically, the exact role of bacterial infection in PDM has been debated for many years. Bacterial infection was thought to be a possible etiological factor of PDM. However, the current overall data are not conclusive as some studies also suggest sterile lesions in PDM patients without invasion of any bacteria [14]. Among the studies that demonstrated the presence of bacterial infection, both aerobes and anaerobes have been found in the subsequent culturing or sequencing of samples from PDM patients, including Pseudomonas aeruginosa and Staphylococcus aureus [12]. Although the diversity of bacterial strains which infected the lesions of PDM might be due to different detecting methods and culture media used in different individual study, the overall results still suggest that a specific pathogenic bacterium may not exist for the infection of PDM [15, 16]. Therefore, we hypothesize that the main cause of this disease may be the consequent immune response following bacterial infection instead of the infection itself. However, there is little data available now on the literature about the role of immune response in this disease. It has been well-established that adaptive immune responses play very important roles in the development of inflammatory diseases, especially in those related to bacterial infection. Key players of the adaptive immune response are T helper (Th) cells [17]. Th cells have been divided into three major subsets based on their different cytokine expression profiles. The Th1 subset is characterized by the production of interferon-γ (IFN-γ) and IL-12; while the major cytokines featured in the Th2 subset are interleukin-4 (IL-4) and IL-10, respectively. The Th17 subset was described more recently and is simply defined by the production of IL-17. As reported, while Th1 subset controls intracellular bacterial infections, the Th2 subset controls parasitic infections and the Th17 subset controls fungal and extracellular bacterial infections, respectively [18]. Since PDM is a condition related to bacterial infection, it is reasonable to assume that Th1 and Th17 may mediate the possible immune responses following bacterial infection in PDM.

In the present study, besides exploring and identifying the possible risk factors for PDM, we also investigate the relationship between bacterial infection and PDM and the significance of the expression of consequent Th1 and Th17 cytokines in this disease. Our results may help to further elucidate the pathogenesis of PDM. Furthermore, since there are very few well-designed investigations tending to explore the risk factors and possible causes for PDM in Chinese patients now, our results here may lay an important ground for the future epidemiological study on this issue in Chinese Han population.

2. Materials and Methods

2.1. Study Population

This was a retrospective nonmatched case control study. Eighty-seven patients with PDM were recruited from the Department of Breast Surgery at the Second Hospital of Shandong University. The study was conducted from January 2011 to March 2015. The inclusion criteria for patients with PDM were as follows: (I) newly diagnosed and histologically confirmed periductal mastitis; (II) Han ethnic group; and (III) no evidence or history of cancer. Eighty-seven healthy controls were collected from the Physical Examination Center of the Second Hospital of Shandong University from June 2015 to August 2015. The criteria for the control group were as follows: (I) normal results on breast physical examinations, breast ultrasound scans, and/or mammographic screening and without any possible benign breast diseases (fibroadenoma, PDM, breast cyst, intraductal papillomas, etc.); (II) Han ethnic group; and (III) no evidence or history of breast cancer. All eligible subjects were women in reproductive age and willing to participate in the study voluntarily. All procedures performed here involving human participants were approved by the Second Hospital of Shandong University Research Committee.

2.2. Pathological Diagnosis

Vacuum-assisted, incisional, or excisional biopsy was performed based on the clinical findings at the time of admission. Pathological results were reviewed by two pathologists. PDM patients were included in this study only if they had confirmed pathological changes. All patients with other possible causes of mammary inflammation were ruled out, such as breast tuberculosis, fat necrosis, and granulomatous lobular mastitis, as well as inflammation due to lactation or pregnancy.

2.3. Data Collection

Possible etiologic factors were written down at the time of admission, including sociodemographic status, smoking status, alcohol consumption, reproductive history, and medical history. In addition, the following information was also obtained: patient age, marital status, menopause status, height, weight, body mass index (BMI), active and passive smoking, alcohol abuse, heart and other chronic disease history, history of allergies, history of benign breast disease, galactostasis, age at menarche, age of first child birth, parity, miscarriage history, and duration of breastfeeding. For individual patient, clinicopathologic characteristics were also collected, including major complaint on presentation, size of lesion, and histology findings.

2.4. Bacteria Detection

For the specimen collection, patients who received any antibiotics before admission and had sinus or fistula or abscess incision drainage were ruled out from the study. Finally, 33 specimens from 31 patients, including 21 pus samples and 12 tissue samples, were collected in this study. Normal tissues adjacent to benign breast pathology (including fibroadenoma, mastalgia, and intraductal papilloma of the breast) were used as control specimens (). Breast tissue samples were collected under aseptic conditions at the time of operation. Tissues were divided into two sections, with one section frozen immediately in liquid nitrogen and another section sent to the laboratory for bacterial culture. Fresh breast specimens were homogenized and incubated onto Columbia blood agar (Babio Biotech Co., Ltd., Jinan, China) and anaerobic blood culture bottles (Biotech Co., Ltd.). The agar plates were incubated at 37°C and humidified incubator was supplied with 10% carbon dioxide. The colonies formed in the plates were picked and analyzed using a MicroScan Walkaway-96 system (Dade-Behring MicroScan, Sacramento, CA). Gram staining and a stain for acid-fast bacilli were conducted for all specimens. All samples were also analyzed by 16S rRNA gene sequencing. Genomic DNA was prepared using the bacterial DNA extraction kit (Tiangen Biotech Co., Ltd., Beijing, China) according to the manufacturer’s recommendations. The hypervariable regions V1–V3 of the 16S rRNA gene were PCR-amplified using universal primers (V3F: 5′-CCAGACTCCTACGGGAGGCAG-3′, V3R: 5′-CGTATTACCGCGGCTGCTG-3′; 27F: 5′-AGA GTT TGA TCM TGG CTC AG-3′, 519R: 5′-GWA TTA CCG CGG CKG CTG-3′) (Sangon Biotech Co., Ltd., Shanghai, China) [19]. The 203 and 492 bp PCR products were purified after agarose gel electrophoresis and sequences were determined using the ABI PRISM 3730 DNA sequencer (Perkin Elmer Inc., Waltham, MA, USA). Nucleotide sequences were analyzed using the National Center for Biotechnology Information BLAST software (https://www.ncbi.nlm.nih.gov).

2.5. Immunohistochemistry

For the patients who were tested for bacterial infection, tissue samples which are mentioned above were also embedded in paraffin () for immunohistochemistry study of proinflammatory cytokines. Normal tissues adjacent to benign breast pathology (including fibroadenoma, mastalgia, and intraductal papilloma of breast) were used as control specimens (). Immunohistochemistry was performed on 4 μm thick sections. And then, the streptavidin-peroxidase-biotin (SP) immunohistochemical method was performed to detect the expression of IFN-γ, IL-12A, and IL-17A. Briefly, after deparaffinization and rehydration, the human tissue sections were incubated in 3% hydrogen peroxide in methanol to quench the endogenous peroxidase activity, followed by incubation with normal goat serum to block nonspecific binding. Samples were then incubated overnight at 4°C with rabbit anti-IFN-γ (1 : 500, ab9657, Abcam, Cambridge, MA, USA), anti-IL-12A (1 : 500, ab131039, Abcam), or anti-IL-17A (1 : 500, ab9565, Abcam). The secondary antibody was from the SP reagent kit (PV9000; Zhongshan Biotech Co., Ltd., Beijing, China). The color reaction was performed with 3,3′-Diaminobenzidine (Zhongshan Biotech Co., Ltd.), counterstained with hematoxylin, dehydrated, treated with xylene, and then mounted. For negative controls, the antibodies were replaced with PBS. To determine the ratio of positive cells for these three cytokines, 5 fields (×400) were randomly examined per slide and scored by two pathologists who are blinded to the patients’ information. The levels of IFN-γ, IL-12A, and IL-17A expression were semiquantitatively expressed using a visual grading system based on the extent of staining (percentage of positive cells graded on scale from 0 to 3: 0, none; 1: 1–30%; 2: 31–60%; 3: >60%) and the intensity of staining (graded on a scale of 0–3: 0, none; 1: weak staining; 2: moderate staining; 3: strong staining). The combination of extent (E) and intensity (I) of staining was obtained by the product of E and I, with EI varying from 0 to 9 for each spot. Low expression was defined as EI ≤ 3, and others were considered high expression [20].

2.6. Statistical Analysis

Statistical analysis was performed with SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). The results were reported as counts (percentage) for the categorical variables, and mean ± standard deviation for the continuous variables. A two-sample Student’s -test was used to compare the difference between the means of the continuous variables. Chi-square test (or Fisher exact test) was used to compare the differences between the proportions if appropriate. Risk factors for PDM were further assessed using both univariate and multivariable (unconditional) logistic regression models. The continuous variables were evaluated according to the clinically relevant categories. The categories for BMI were based on the criteria of being overweight and obese for Chinese individuals (overweight: 24–27.9 kg/m2; obese: ≥28 kg/m2) [21]. The categories for other continuous variables were on the basis of references (menarche age ≤ 14 years, >14 years; times of parity ≤ 1, >1; age at birth of first child ≤ 27 years, >27 years; duration of breastfeeding ≤ 12 months, >12 months) [22, 23]. Odds ratio (OR) with 95% confidence interval (95% CI) was used to estimate the association between risk factors and exposure. The significance level was set to (two-tailed).

3. Results

3.1. Study Population Characteristics

To investigate the risk factors for PDM, 87 patients and 87 healthy control subjects were enrolled in this study. The characteristics of patients and controls are summarized in Table 1. The median age of patients at presentation was 34 (range 20–62) years, and the median age of controls was 34 (range 26–45) years. The median age did not differ significantly between the two groups (). The majority of subjects in this study were married. There were no statistically significant differences between these two groups in terms of for the history of hypertension, type 2 diabetes mellitus, heart disease, or any history of allergy. Neither alcohol abuse nor active smoking was reported in the case and control groups. There was not any form of breast cancer in these patients of PDM confirmed by pathologic examination.


VariableCases ()Controls ()

Marriage
 Yes 82 (94.25)86 (98.85)0.211
 No5 (5.75)1 (1.15)
Menopause
 Yes 6 (6.90)0 (0)0.029
 No81 (93.10)87 (100)
Hypertension
 Yes 5 (5.75)0 (0)0.059
 No82 (94.25)87 (100)
Diabetes mellitus
 Yes 5 (5.75)0 (0)0.059
 No82 (94.25)87 (100)
Heart diseases
 Yes 4 (4.60)0 (0)0.121
 No83 (95.40)87 (100)
Passive smoking
 Yes 23 (46.94)16 (35.56)0.263
 No26 (53.06)29 (64.44)
History of allergies
 Yes 9 (10.34)7 (8.05)0.670
 No78 (89.66)80 (91.95)

Note. Data are number (%) of patients.
values were determined with the chi-square test.

Most patients had unilateral breast disease, with only 8 patients exhibiting bilateral symptoms. Breast mass with or without pain was the most common complaint. The clinical presentations were summarized in Table 2. The median duration between last pregnancy and onset of PDM was 5 years (range 1–35 years), which implied that that reproductive age might relate to PDM to some degree (Figure 1).


CharacteristicValue

Mean size of mass (cm)
Affected sides
 Right34 (39.08)
 Left45 (51.72)
 Bilateral8 (9.20)
Quadrant(s)
 Upper-outer20 (22.99)
 Lower-outer8 (9.20)
 Upper-inner9 (10.34)
 Lower-inner9 (10.34)
 Two or more quadrants15 (17.24)
 Subareolar region26 (29.89)
Clinical presentation
 Mass without pain63 (72.41)
 Mass with pain15 (17.24)
 Erythroswelling31 (35.63)
 Nipple discharge6 (6.90)
 Sinus12 (13.79)
 Nipple retraction24 (27.59)
Biopsy methods
 Incisional or excisional biopsy24 (27.59)
 Vacuum-assisted biopsy63 (72.41)

Note. Data are number (%) of patients, unless otherwise indicated.
3.2. Univariate and Multivariate Analysis for the Risk Factors for PDM

To examine the relationship between multiple factors and PDM, a univariate analysis was performed. The results were shown in Table 3. An analysis of the full dataset indicated that overweight/obesity (OR, 3.06; 95% CI, 1.53–6.13; ), a late onset of menarche (OR, 4.31; 95% CI, 1.95–9.50; ), having more than one child (OR, 2.75; 95% CI, 1.18–6.41; ), history of benign breast disease (OR, 4.54; 95% CI, 1.07–10.14; ), and nipple retraction (OR, 32.76; 95% CI, 4.32–248.61; ) were statistically significant risk factors for PDM. Late age at first birth (OR, 0.22; 95% CI, 0.09–0.57; ) had a protective effect for the disease. When stratified at 12 months, duration of breastfeeding was not significantly related to PDM.


VariableCases ()Controls ()OR (95% CI)

Age (years)
 <3548 (55.17)56 (64.37)1.0 (Ref)0.217
 ≥3539 (44.83)31 (35.63)1.47 (0.80–2.70)
BMI (kg/m2)
 <2434 (39.08)65 (74.71)1.0 (Ref)0.002
 ≥2434 (39.08)20 (22.99)3.25 (1.63–6.48)
 Unknown19 (21.84)2 (2.30)
Age at menarche (years)
 ≤1457 (65.52)74 (85.06)1.0 (Ref)0.001
 >1430 (34.48)10 (11.49)3.90 (1.76–8.62)
 Unknown0 (0.00)3 (3.45)
Parity
 ≤164 (73.56)72 (82.76)1.0 (Ref)0.019
 >122 (25.29)9 (10.34)2.75 (1.18–6.41)
 Unknown1 (1.15)6 (6.90)
Miscarriages
 No23 (26.44)25 (28.74)1.0 (Ref)0.470
 Yes25 (28.74)36 (41.38)0.76 (0.35–1.62)
 Unknown39 (44.82)26 (29.88)
Age at birth of first child (years)
 ≤2734 (39.08)26 (29.89)1.0 (Ref)0.001
 >278 (9.20)29 (33.33)0.21 (0.08–0.54)
 Unknown45 (51.72)32 (36.78)
Duration of breastfeeding (months)
 ≤1234 (39.08)42 (48.28)1.0 (Ref)0.688
 >1236 (41.38)39 (44.83)1.14 (0.60–2.16)
 Unknown17 (19.54)6 (6.89)
History of benign breast disease
 Yes6 (6.90)3 (3.45)4.54 (1.07–19.14)0.039
 No37 (42.53)84 (95.55)1.0 (Ref)
 Unknown44 (50.57)0 (0.00)
Galactostasis
 Yes23 (26.44)32 (36.78)0.86 (0.44–1.70)0.670
 No40 (45.98)48 (55.17)1.0 (Ref)
 Unknown24 (27.58)7 (8.05)
Nipple retraction
 Yes24 (27.59)1 (1.15)32.76 (4.32–248.61)0.001
 No63 (72.41)86 (98.85) 1.0 (Ref)

Note. Data are number (%) of patients. BMI: body mass index, calculated as weight in kilograms divided by the square of height in meters. OR: odd ratio. CI: confidence interval.
binary logistic regression.

All factors in the univariate analysis with values < 0.2 were regarded as candidate predictors for a logistic regression model and a backward variable selection process was used. In the multivariable model (Table 4), overweight/obesity (OR, 1.36; 95% CI, 1.08–1.70; ) and late onset of menarche (OR, 2.41; 95% CI, 1.38–4.21; ) were independent predictors of PDM. In contrast, late age at first birth had a protective effect against PDM (OR, 0.18; 95% CI, 0.03–0.98; ).


VariableBS.E.WaldOR95% CI

Overweight/obesity0.310.127.001.361.08–1.700.008
Age at first birth0.863.920.180.03–0.980.048
Age at menarche0.880.299.532.411.38–4.210.002

3.3. Microorganism Infection in PDM

To investigate the role of bacterial infection in the development of PDM, multiple microorganism detection method was employed in this study. Acid-fast bacilli staining was negative in both case and control groups. However, colony formation was found on only one pus specimen plate in bacterial culturing study and two distinct bacterial strains were further identified as Brevibacterium flavum and a rare Gram-positive bacterium, Bacillus cereus, with 16S rRNA gene sequencing. There was no anaerobic bacterial growth from any sample.

Furthermore, with sequencing of the 16S rRNA gene, we demonstrated that one or more species of bacteria could be detected in all of the patient specimens, but all the control tissues from the benign breast disease were negative on this test. In the case group, a mixture of different bacterial infection was most often observed (38.71%), followed by single bacterial infection of Pseudomonas spp. (29.03%) (Table 5). Enterococcus faecium, Corynebacterium kroppenstedtii, Bacillus firmus, Sporosarcina, and Staphylococcus aureus were also found in some samples. This result validated the assumption that bacterial infection might be an etiological factor for PDM.


Bacteria (%) ()

Mixture of different bacteria12 (38.71)
Pseudomonas
Pseudomonas aeruginosa5 (16.13)
Uncultivated Pseudomonas2 (6.45)
Pseudomonas delhiensis1 (3.23)
Pseudomonas otitidis1 (3.23)
Enterococcus faecium2 (6.45)
Corynebacterium kroppenstedtii1 (3.23)
Bacillus firmus1 (3.23)
Sporosarcina1 (3.23)
Staphylococcus aureus1 (3.23)
Uncultured bacterium clone4 (12.90)

3.4. Expression of Proinflammatory Cytokines in PDM

As bacteria were found in the lesions of PDM, we then test whether the critical proinflammatory cytokines from following immune responses, IFN-γ, IL-12A, and IL-17A, were involved in the disease progression with an IHC method (Figure 2). After staining and taking photographs, a scoring evaluation of the density for each cytokine in this IHC photographs was performed and data were summarized in Table 6. As shown in Table 7, the expressions of IFN-γ and IL-12A in stromal inflammatory cells of the breast were increased in PDM compared to normal breast tissues. However, there were no significant differences in the expression of IL-17A between these two groups.


ScoreIFN-γIL-12AIL-17A
CaseControlCaseControlCaseControl

0210212
12303101
25131112810
3126214
48371103
6904102
8000000
9402100
Absent0000

were lost in the process of IHC.

CytokinesCaseControl

Low expression of IFN-1019<0.001
High expression of IFN-γ213
Low expression of IL-12A13190.022
High expression of IL-12A173
Low expression of IL-17A20170.404
High expression of IL-17A105

values were determined with the chi-square test.
expression was defined as the total score ≤ 3, and others were defined as high expression.

To investigate the cytokines expression profiles at different stages of PDM, the expressions of IFN-γ, IL-12A, and IL-17A were then analyzed by grouping with the presence or absence of abscess. Fifteen patients with abscess formation in their lesions and 16 patients without abscess formation were included in this study. As shown in the Figure 3, higher expression levels of IFN-γ and IL-17A were found in stromal inflammatory cells from PDM patients with abscess formation than those without abscess formation. These results suggest that proinflammatory cytokines may play an important role in the progression of the disease of PDM, especially the IFN-γ and IL-12A. As mentioned above, these two cytokines are key factors involved in the Th1 mediated adaptive immune responses following bacterial infection.

4. Discussion

Smoking, obesity, diabetes mellitus, and reproductive factors have been considered as significant risk factors for PDM in previous studies [10, 24]. The results of the present study confirmed that overweight/obesity and the late onset of menarche were independent risk factors for PDM, while late age at first birth had a protective effect. In addition, our results also suggested that nipple retraction was related to PDM. Bacterial infection could be found in all samples of PDM patients by 16S rRNA gene sequencing but not in the samples from the control subjects. Among the infected samples in PDM patients, a mixture of different bacterial strains was the most common condition which could be seen, and then followed by single Pseudomonas spp. infection. IFN-γ and IL-12A were upregulated in PDM compared to normal breast tissues, but the expression of IL-17A was not significantly different from control samples. Moreover, there are increased expression pattern for both IFN-γ and IL-17A in PDM which suggested a following immune response after bacterial infection may contribute the deterioration of PDM.

The incidence of PDM is increasing rapidly during the past decades. Indeed, in our previous investigation, the detection rate of mammary ductal ectasia was 0.24% (147/61,102) [25]. However, the etiology of PDM is unclear yet, mostly due to lack of conclusive evidences from previous study. Although some studies suggest smoking is a risk factor for PDM [11, 12], smoking was not found to be closely related to PDM in the present study. One of the plausible reasons might be the low prevalence of smoking among Chinese women [26].

Obesity is related to low-grade chronic inflammation, which can disrupt immune function [27, 28]. Furthermore, obesity can directly influence local mammary estrogen and inflammation [29]. Gollapalli et al. [8] reported that obesity was a risk factor for breast abscess. Bharat et al. [13] found that higher BMI values were also associated with nonpuerperal abscess. They also reported similar results in cases of granulomatous lobular mastitis. In PDM, however, they did not find a significant effect of obesity on patients when compared with health controls [30]. In our study, data demonstrated obesity is another risk factor for PDM. Obesity may directly disrupt the local immune functioning of the breast and exacerbate the development of PDM.

The relationship between reproductive factors and PDM is very interesting. Inconsistent with the finding reported previously from literature in which parity was not found to be associated with the risk for duct ectasia [31], our results suggest that reproductive factors were related to PDM. We also found late onset of menarche was a significant risk factor for PDM while increased age at first birth was a protective factor. The changes of serum prolactin and lactation in patients may be responsible for the above association. The exact mechanism underlying this relationship is still unknown; future investigation focusing on theses hormones is warranted.

The relationship between nipple retraction and PDM has been well-documented [32]. Nipple retraction could induce breast deformation and influence the process of lactation. Furthermore, it also can obstruct drainage and lead to an accumulation of massive substances in ducts, which is termed mastitis [33]. In this study, we confirmed that nipple retraction was a risk factor for PDM. The prevalence rate of nipple retraction is approximately 3.26% according to previous report [34]. But, over one quarter of PDM patients experienced nipple retraction in our study.

Bacterial infection is considered to be another possible etiology of PDM, although it has been a long-standing controversial problem. Al Benwan et al. [15] found that S. aureus was the predominant pathogen, followed by Bacteroides spp., Anaerobic strep., and P. aeruginosa. However, the relationship between bacteria and PDM was not confirmed in other report [31]. Here, we provided more evidence to confirm for this assumption. Inconsistent with previous report [35], we did not find that either S. aureus was the most common bacterium in PDM or anaerobic bacteria was associated with this disease based on our current data. Interestingly, the bacteria identified here were those microorganisms which are often related to community-acquired infection, including Pseudomonas spp. and S. aureus. Collectively, these finding suggests that bacterial infection may only be acting as an induction factor and the immune system which are following the bacterial infection might play a major role in the development of PDM. However, more study is needed for the future to determine the common route in which the bacterial infection and the following immune response converge.

IFN-γ and IL-12A are characteristic Th1 cytokines [36]. Th1 cells are important for the eradication of invading pathogens, including bacteria, parasites, yeast, and viruses [37]. In this study, the expressions of IFN-γ and IL-12A were upregulated in breast stromal inflammatory cells of PDM patients. Recently, a lineage of CD4+ T cells producing IL-17A was described and accordingly named as Th17 cells. IL-17A has been shown to be important for host defense against pathogens [38]. However, in our study, there was no significant difference in IL-17A expression between the two groups. As IFN-γ and IL-12A were detected in PDM tissue samples, there is a rationale to conclude that the Th1 immune response plays a role in this disease. The mechanism by which these cytokines contribute to the course of disease is still unknown and needs further investigation.

The strengths of the present study include the following: (a) a relatively large population of patients was included; (b) the assessment of tissue was done by two histopathologists experienced in breast inflammation. However, our study also had several limitations. First, this was a nonmatched case control study and there might be some uncontrolled biases which may influence the credibility of the results. Second, there was an issue with missing data, especially the data of reproductive factors, which may also lead to the bias of results. Finally, we have not investigated the mechanism by which IFN-γ and IL-12A participated in the course of the disease.

5. Conclusions

The results of the present study indicated that overweight/obesity and later onset of menarche are independent risk factors for PDM. In contrast, age of first birth >27 years is a protective factor for PDM. The importance of these reproductive factors to the risk of PDM has not been previously reported and will provide important novel information to broaden the avenue of investigating the etiology of PDM in the future. We also confirm that bacterial infection with a mixture of different bacterial species is a closely associated with the pathogenesis of PDM. Moreover, proinflammatory cytokines, IFN-γ and IL-12A, were also shown to be associated with PDM, which indicates that the Th1 immune response may closely relate to this disease. Therefore, PDM could be an inflammatory disease related to bacterial infection and consequent immune responses with increased cytokines. As far as we know, this is first report about the possible immune responses following bacterial infection which is involved in development of PDM disease, and more research is needed for the future to further investigate the pathogenesis of PDM on the mechanism by which bacterial infection and consequent immune responses affect the progression of the disease.

Ethical Approval

All procedures performed here involving human participants were in accordance with the ethical standards of the Second Hospital of Shandong University Research Committee and with the 1964 Helsinki Declaration, its later amendments, and comparable ethical standards.

Informed consent was obtained from all participants included in the study.

Competing Interests

All authors declare that there are no competing interests regarding the publication of this paper.

Authors’ Contributions

Dr. Zhigang Yu and Dr. Liang Li have equal contribution to this article.

Acknowledgments

The authors thank the patients and staffs at the Department of Breast Surgery of Second Hospital of Shandong University for their collaboration and support. This study was funded by the Youth Fund of the Second Hospital of Shandong University (Y2014010030). Fei Zhou has received research grants from the Second Hospital of Shandong University.

References

  1. K. Ramalingam, A. Srivastava, S. Vuthaluru, A. Dhar, and R. Chaudhry, “Duct Ectasia and periductal mastitis in Indian women,” Indian Journal of Surgery, vol. 77, supplement 3, pp. 957–962, 2015. View at: Publisher Site | Google Scholar
  2. J. M. Dixon, “Periductal mastitis/duct ectasia,” World Journal of Surgery, vol. 13, no. 6, pp. 715–720, 1989. View at: Publisher Site | Google Scholar
  3. X. Zhang, Y. Lin, Q. Sun, and H. Huang, “Dermo-glandular flap for treatment of recurrent periductal mastitis,” Journal of Surgical Research, vol. 193, no. 2, pp. 738–744, 2015. View at: Publisher Site | Google Scholar
  4. R. M. S. Rahal, R. De Freitas-Júnior, and R. R. Paulinelli, “Risk factors for duct ectasia,” Breast Journal, vol. 11, no. 4, pp. 262–265, 2005. View at: Publisher Site | Google Scholar
  5. R. Mansel, D. Webster, and H. Sweetland, Hughes, Mansel & Webster's Benign Disorders and Diseases of the Breast (Third Edition), Saunders, Philadelphia, Pa, USA, 2009.
  6. M. H. Lequin, J. van Spengler, R. van Pel, C. van Eijck, and H. van Overhagen, “Mammographic and sonographic spectrum of non-puerperal mastitis,” European Journal of Radiology, vol. 21, no. 2, pp. 138–142, 1995. View at: Publisher Site | Google Scholar
  7. R. Tomczak, A. Rieber, H. Zeitler, N. Rilinger, R. Kreienberg, and H. J. Brambs, “The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma,” RöFo: Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin, vol. 165, no. 2, pp. 148–151, 1996. View at: Google Scholar
  8. V. Gollapalli, J. Liao, A. Dudakovic, S. L. Sugg, C. E. H. Scott-Conner, and R. J. Weigel, “Risk factors for development and recurrence of primary breast abscesses,” Journal of the American College of Surgeons, vol. 211, no. 1, pp. 41–48, 2010. View at: Publisher Site | Google Scholar
  9. R. Risager and N. Bentzon, “Smoking and increased risk of mastitis,” Ugeskrift for Laeger, vol. 172, no. 33, pp. 2218–2221, 2010. View at: Google Scholar
  10. H. N. Oltean, A. S. Soliman, O. S. Omar et al., “Risk factors for chronic mastitis in Morocco and Egypt,” International Journal of Inflammation, vol. 2013, Article ID 184921, 10 pages, 2013. View at: Publisher Site | Google Scholar
  11. P. Schafer, C. Furrer, and B. Mermillod, “An association of cigarette smoking with recurrent subareolar breast abscess,” International Journal of Epidemiology, vol. 17, no. 4, pp. 810–813, 1988. View at: Publisher Site | Google Scholar
  12. V. Sakka, “Nonpuerperal breast infection: epidemiology and predictors for recurrences,” Clinical Microbiology and Infection, vol. 18, p. 237, 2012. View at: Google Scholar
  13. A. Bharat, F. Gao, R. L. Aft, W. E. Gillanders, T. J. Eberlein, and J. A. Margenthaler, “Predictors of primary breast abscesses and recurrence,” World Journal of Surgery, vol. 33, no. 12, pp. 2582–2586, 2009. View at: Publisher Site | Google Scholar
  14. N. J. Bundred, J. M. J. Dixon, A. B. Lumsden et al., “Are the lesions of duct ectasia sterile?” British Journal of Surgery, vol. 72, no. 10, pp. 844–845, 1985. View at: Publisher Site | Google Scholar
  15. K. Al Benwan, A. Al Mulla, and V. O. Rotimi, “A study of the microbiology of breast abscess in a teaching hospital in Kuwait,” Medical Principles and Practice, vol. 20, no. 5, pp. 422–426, 2011. View at: Publisher Site | Google Scholar
  16. P.-L. Giacalone, G. Rathat, S. Fournet, and C. Rouleau, “Surgical treatment of recurring subareolar abscess using oncoplastic techniques,” Journal of Visceral Surgery, vol. 147, no. 6, pp. e389–e394, 2010. View at: Publisher Site | Google Scholar
  17. A. Geremia, P. Biancheri, P. Allan, G. R. Corazza, and A. Di Sabatino, “Innate and adaptive immunity in inflammatory bowel disease,” Autoimmunity Reviews, vol. 13, no. 1, pp. 3–10, 2014. View at: Publisher Site | Google Scholar
  18. P. Miossec and J. K. Kolls, “Targeting IL-17 and TH17 cells in chronic inflammation,” Nature Reviews Drug Discovery, vol. 11, no. 10, pp. 763–776, 2012. View at: Publisher Site | Google Scholar
  19. Y. Khosravi, Y. Dieye, B. H. Poh et al., “Culturable bacterial microbiota of the stomach of helicobacter pylori positive and negative gastric disease patients,” The Scientific World Journal, vol. 2014, Article ID 610421, 10 pages, 2014. View at: Publisher Site | Google Scholar
  20. R. Maréchal, P. Demetter, N. Nagy et al., “High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma,” British Journal of Cancer, vol. 100, no. 9, pp. 1444–1451, 2009. View at: Publisher Site | Google Scholar
  21. M. Yao, Y. Wu, Q. Fang, L. Sun, T. Li, and H. Qiao, “Association of ADIPOQ variants with type 2 diabetes mellitus susceptibility in ethnic han Chinese from Northeast China,” Journal of Diabetes Investigation, vol. 7, no. 6, pp. 853–859, 2016. View at: Publisher Site | Google Scholar
  22. Q. Zhang, L.-Y. Liu, F. Wang, K. Mu, and Z.-G. Yu, “The changes in female physical and childbearing characteristics in china and potential association with risk of breast cancer,” BMC Public Health, vol. 12, article 368, 2012. View at: Publisher Site | Google Scholar
  23. J. Kotsopoulos, J. Lubinski, L. Salmena et al., “Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers,” Breast Cancer Research, vol. 14, no. 2, article R42, 2012. View at: Google Scholar
  24. Y. Dong, J.-J. Yu, Y. Shibahara et al., “Intercellular adhesion molecule 1/2 and E-selectin in plasma cell mastitis: immunohistochemical study of 35 cases,” Human Pathology, vol. 45, no. 3, pp. 606–610, 2014. View at: Publisher Site | Google Scholar
  25. Y. Y. Li, J. J. Du, Q. Liu, and Z. G. Yu, “Screening for breast diseases among 61,102 women in Shandong Province,” Journal of Shandong University, vol. 49, no. 8, pp. 157–160, 2011. View at: Google Scholar
  26. Y.-M. Xu, H.-H. Chen, F. Li et al., “Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapy,” PLOS ONE, vol. 9, no. 2, Article ID e88478, 2014. View at: Publisher Site | Google Scholar
  27. F. M. Wensveen, S. Valentić, M. Šestan, T. Turk Wensveen, and B. Polić, “The “Big Bang” in obese fat: events initiating obesity-induced adipose tissue inflammation,” European Journal of Immunology, vol. 45, no. 9, pp. 2446–2456, 2015. View at: Publisher Site | Google Scholar
  28. Y. B. Shaik-Dasthagirisaheb, A. Kantarci, and F. C. Gibson III, “Immune response of macrophages from young and aged mice to the oral pathogenic bacterium Porphyromonas gingivalis,” Immunity & Ageing, vol. 7, article 15, 2010. View at: Publisher Site | Google Scholar
  29. K. A. Brown, “Impact of obesity on mammary gland inflammation and local estrogen production,” Journal of Mammary Gland Biology and Neoplasia, vol. 19, no. 2, pp. 183–189, 2014. View at: Publisher Site | Google Scholar
  30. B. Al-Khaffaf, F. Knox, and N. J. Bundred, “Idiopathic granulomatous mastitis: a 25-year experience,” Journal of the American College of Surgeons, vol. 206, no. 2, pp. 269–273, 2008. View at: Publisher Site | Google Scholar
  31. R. M. S. Rahal, R. F. Júnior, C. Reis, F. C. Pimenta, J. C. A. Netto, and R. R. Paulinelli, “Prevalence of bacteria in the nipple discharge of patients with duct ectasia,” International Journal of Clinical Practice, vol. 59, no. 9, pp. 1045–1050, 2005. View at: Publisher Site | Google Scholar
  32. M. N. Hartley, J. Stewart, and E. A. Benson, “Subareolar dissection for duct ectasia and periareolar sepsis,” The British Journal of Surgery, vol. 78, no. 10, pp. 1187–1188, 1991. View at: Publisher Site | Google Scholar
  33. J. Ming, G. Meng, Q. Yuan et al., “Clinical characteristics and surgical modality of plasma cell mastitis: analysis of 91 cases,” The American Surgeon, vol. 79, no. 1, pp. 54–60, 2013. View at: Google Scholar
  34. H. S. Park, C. H. Yoon, and H. J. Kim, “The prevalence of congenital inverted nipple,” Aesthetic Plastic Surgery, vol. 23, no. 2, pp. 144–146, 1999. View at: Publisher Site | Google Scholar
  35. F. N. L. Versluijs-Ossewaarde, R. M. H. Roumen, and R. J. A. Goris, “Subareolar breast abscesses: characteristics and results of surgical treatment,” The Breast Journal, vol. 11, no. 3, pp. 179–182, 2005. View at: Publisher Site | Google Scholar
  36. Y. Luo, H. Yamada, D. P. Evanoff, and X. Chen, “Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells,” Clinical and Experimental Immunology, vol. 146, no. 1, pp. 181–188, 2006. View at: Publisher Site | Google Scholar
  37. K. J. Rautajoki, M. K. Kyläniemi, S. K. Raghav, K. Rao, and R. Lahesmaa, “An insight into molecular mechanisms of human T helper cell differentiation,” Annals of Medicine, vol. 40, no. 5, pp. 322–335, 2008. View at: Publisher Site | Google Scholar
  38. B. Stockinger and M. Veldhoen, “Differentiation and function of Th17 T cells,” Current Opinion in Immunology, vol. 19, no. 3, pp. 281–286, 2007. View at: Publisher Site | Google Scholar

Copyright © 2017 Lu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views15083
Downloads1019
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.